All Pharma News
price-trendAsk Us
Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075

Regor Initiates Phase 2 Study of Oral Once-daily GLP-1 Agonist RGT-075
PR NEWSWIRE
08 Mar 2024
Share Share
Regor Announces Safety And Single Agent Efficacy Data Evaluating RGT-419B

Regor Announces Safety And Single Agent Efficacy Data Evaluating RGT-419B
PR NEWSWIRE
07 Dec 2023
Share Share
Regor notches minor victory in trade secrets feud with Pfizer

Regor notches minor victory in trade secrets feud with Pfizer
Fraiser Kansteiner FIERCE BIOTECH
08 Feb 2023
Share Share
Ex-Pfizer staffers slap back at trade secret stealing accusations

Ex-Pfizer staffers slap back at trade secret stealing accusations
P. Schloesser ENDPTS
24 Mar 2022
Share Share
Building a New Generation AI Engine and Jointly Accelerating World-Class Innovative Drug Discovery and Development

Building a New Generation AI Engine and Jointly Accelerating World-Class Innovative Drug Discovery and Development
PRESS RELEASE
24 Mar 2022
Share Share
Pfizer accuses former employees of stealing trade secrets

Pfizer accuses former employees of stealing trade secrets
E. Silverman STATNEWS
04 Feb 2022
Share Share
FDA Authorizes Regor`s First-in-Human Clinical Trial with RGT-419B for Oncology

FDA Authorizes Regor`s First-in-Human Clinical Trial with RGT-419B for Oncology
ASIAONE
28 Dec 2021
Share Share
Lilly and Regor sign deal to develop treatments for metabolic disorders

Lilly and Regor sign deal to develop treatments for metabolic disorders
PHARMACEUTICAL-TECHNOLOGY
10 Dec 2021
Share Share